Publication
What is happening with stablecoins in Canada?
Canadian securities regulators have taken a pragmatic approach to the trading of crypto assets.
United States | Publication | December 2022
On December 1, 2022, the Office for Civil Rights (OCR) at the US Department of Health and Human Services (HHS) issued a 12-page Bulletin highlighting the obligations of HIPAA covered entities (including providers and health plans) and business associates that use online tracking technologies on websites or mobile applications. The Bulletin cautions that HIPAA-regulated entities are not permitted to use tracking technologies in a manner that results in impermissible disclosures of protected health information (PHI) to tracking technology vendors or any other violations of the HIPAA Privacy, Security and Breach Notification Rules. To that end, regulated entities must ensure that such disclosures are permitted by the Privacy Rule and enter into a business associate agreement (BAA) with these tracking technology vendors “to ensure PHI is protected in accordance with HIPAA Rules.”
For a detailed overview of the Bulletin, including technical steps you can take, please see the following blog post, "HHS: Online trackers without prior authorization and BAAs can violate HIPAA," produced by Norton Rose Fulbright’s dedicated Information Governance, Privacy and Cybersecurity practice group.
Publication
Canadian securities regulators have taken a pragmatic approach to the trading of crypto assets.
Publication
For anyone seeking or about to seek an injunction – be forewarned. Either bring your “A” game when filing your application and evidence, or save your time and money.
Publication
Corporations are considered separate legal persons distinct from the people that run them. But, they do not have their own minds or willpower. This raises a question when statutory or common law tests require a finding as to the intent of the corporation.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023